Ronit Mazor
Impact in
- Biotechnology top 2%
- Transgenic Plants and Applications
- Microbial Inactivation Methods
- Immunology top 5%
- Toxin Mechanisms and Immunotoxins
- Immunotherapy and Immune Responses
Papers in
- Immunology 18
- Toxin Mechanisms and Immunotoxins 15
- Immunotherapy and Immune Responses 3
-
- Transgenic Plants and Applications 10
- Microbial Inactivation Methods 5
- Co-authors
- Ira Pastan (16 shared papers)Masanori Onda (4 shared papers)Emily M. King (4 shared papers)Richard Beers (3 shared papers)Chris King (2 shared papers)David Baker (2 shared papers)Raffit Hassan (3 shared papers)Itai Benhar (2 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Molecular Cancer Therapeutics (2 papers)Frontiers in Immunology (2 papers)Cellular Immunology (2 papers)Molecular Therapy — Methods & Clinical Development (2 papers)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Ronit Mazor
24 papers receiving 814 citations
Peers
Comparison fields: 5 of 67
- Biotechnology 302
- Immunology 478
- Radiology, Nuclear Medicine and Imaging 292
- Biophysics 33
- Oncology 128
Countries citing papers authored by Ronit Mazor
This map shows the geographic impact of Ronit Mazor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronit Mazor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronit Mazor more than expected).
Fields of papers citing papers by Ronit Mazor
This network shows the impact of papers produced by Ronit Mazor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronit Mazor. The network helps show where Ronit Mazor may publish in the future.
Co-authors
The 25 scholars most cited alongside Ronit Mazor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 104 | |
| 2 | 2014 | 94 | |
| 3 | 2016 | 91 | |
| 4 | 2012 | 85 | |
| 5 | 2020 | 71 | |
| 6 | 2018 | 59 | |
| 7 | 2018 | 45 | |
| 8 | 2016 | 42 | |
| 9 | 2007 | 38 | |
| 10 | 2015 | 35 | |
| 11 | 2015 | 34 | |
| 12 | 2018 | 29 | |
| 13 | 2022 | 25 | |
| 14 | 2015 | 21 | |
| 15 | 2017 | 20 | |
| 16 | 2018 | 17 | |
| 17 | 2018 | 11 | |
| 18 | 2023 | 7 | |
| 19 | 2016 | 4 | |
| 20 | 2023 | 2 |
About Ronit Mazor
Ronit Mazor is a scholar working on Immunology, Biotechnology, Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 840 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (15 papers), Transgenic Plants and Applications (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), CAR-T cell therapy research (7 papers), Microbial Inactivation Methods (5 papers), Virus-based gene therapy research (5 papers), Immunotherapy and Immune Responses (3 papers) and Bacillus and Francisella bacterial research (3 papers). The work is most often cited by research in Biotechnology (302 citations), Immunology (478 citations), Radiology, Nuclear Medicine and Imaging (292 citations), Biophysics (33 citations) and Oncology (128 citations). Ronit Mazor has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Ira Pastan, Masanori Onda, Emily M. King, Richard Beers, Chris King, David Baker, Raffit Hassan, Itai Benhar, Marion Pepper and Jonathan L. Linehan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Molecular Cancer Therapeutics, Frontiers in Immunology, Cellular Immunology and Molecular Therapy — Methods & Clinical Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.